Free Trial

Pasithea Therapeutics (KTTA) News Today

Pasithea Therapeutics logo
$0.79 -0.01 (-0.73%)
Closing price 09/5/2025 03:59 PM Eastern
Extended Trading
$0.77 -0.02 (-2.56%)
As of 09/5/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

KTTA Latest News

KTTA Pasithea Therapeutics Corp. - Seeking Alpha
Pasithea announces Safety Review Committee recommendation
Big Mid-Week Move From This Small Biotech
Pasithea Therapeutics announces SRC recommended proceeding to cohort 4
Get Pasithea Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for KTTA and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KTTA Media Mentions By Week

KTTA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KTTA
News Sentiment

1.00

0.72

Average
Medical
News Sentiment

KTTA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KTTA Articles
This Week

1

1

KTTA Articles
Average Week

Get the Latest News and Ratings for KTTA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Pasithea Therapeutics and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:KTTA) was last updated on 9/7/2025 by MarketBeat.com Staff
From Our Partners